Contract Manufacturing

Covectra launches StellaGuard ‘smart’ label anti-counterfeiting

22-Feb-2021 By Jenni Spinner

The on-pack technology enables consumers, retailers and others to harness mobile devices in order to verify the authenticity of pharmaceutical products.

On-demand capabilities help drug developers in a pinch

18-Feb-2021 By Jenni Spinner

With demand for fast-tracking therapies, vaccines and other products increasing, companies like Azzur Group offer the ability to add capabilities quickly.

Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

18-Feb-2021 By Jane Byrne

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).

PwC joins Medicines Manufacturing Innovation Centre

11-Feb-2021 By Jenni Spinner

The global professional services firm has signed on the newest partner in the collaboration, aimed toward promoting innovation in pharma manufacturing.

WuXi STA to buy Bristol Myers Squibb’s Couvet, Switzerland manufacturing facility

02-Feb-2021 By Rachel Arthur

WuXi STA will purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland: giving the CDMO its first facility in Europe.

‘Cognitive’ supply chain approach boosts safety, efficiency: FourKites

21-Jan-2021 By Jenni Spinner

A leader from the supply-chain specialist explains vulnerabilities and challenges unique to pharma, and how professionals can safeguard and streamline.

Continuus lands $69.3m US drug manufacturing contract

21-Jan-2021 By Jenni Spinner

The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines for a range of conditions.

Fight against pharma counterfeiting must go deeper: TruTag

13-Jan-2021 By Jenni Spinner

A leader from the anti-counterfeit solutions firm says that while packaging-level efforts may have an effect, on-dose technology is worth a closer look.

Global alliance unites pharma pros to battle counterfeiting

13-Jan-2021 By Jenni Spinner

Fight the Fakes gathers manufacturers and other stakeholders to brainstorm on ways to combat falsified medicines and safeguard the world’s medicine supply.

Pharmaceutical firms warming up to outsourcing: ReAgent

07-Jan-2021 By Jenni Spinner

A leader from the chemical manufacturing firm notes pharma companies are showing increased interest in contracting out their manufacturing functions.

Supply chain woes can lead to billion-dollar problems: Cloudleaf

23-Dec-2020 By Jenni Spinner

A new survey from the supply-chain analysis company revals inefficiencies, inaccurate data and other flaws can be costly in terms of revenue, reputation and patient lives.

Stay on top of your pharma supply chain in 2021: PCI

17-Dec-2020 By Jenni Spinner

According to an executive from the drug development services company, pharma professionals should pay close attention to supply chain continuity and safety in the coming year.

Looking back, thinking ahead: industry leaders talk trends

16-Dec-2020 By Jenni Spinner

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

CPhI report looks ahead to post-COVID pharma world

08-Dec-2020 By Jenni Spinner

The industry analysis dives into likely developments in supply chain, impact of the new White House occupant, CDMO growth and other key areas.

Almac secures grant to scale COVID-19 drug production

25-Nov-2020 By Jenni Spinner

The company has received a $500,000 grant from the COVID-19 Therapeutics Accelerator to develop manufacturing processes for the antiviral drug remdesivir.